MMP9 and cancer: Moreover, the results were also similar to some tumor vitro studies, genetic ablation of MMP9 in tumor recipients, resulting in decreased MVD in developing tumors and even preventing the angiogenic switch during cancer progression, provided original evidence for the functional involvement of host MMP9 in tumor angiogenesis [12].